Beth C. Seidenberg - 06 Jun 2025 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Issuer symbol
SGMT
Transactions as of
06 Jun 2025
Net transactions value
$0
Form type
4
Filing time
10 Jun 2025, 17:42:20 UTC
Previous filing
02 Jun 2025
Next filing
22 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SEIDENBERG BETH C Director SAGIMET BIOSCIENCES INC., 155 BOVET ROAD, SUITE 303, SAN MATEO /s/ Elizabeth Rozek, Attorney-in-Fact 10 Jun 2025 0001184592

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGMT Stock Option (Right to Buy) Award $0 +28,522 $0.000000 28,522 06 Jun 2025 Series A Common Stock 28,522 $5.56 Direct F1
transaction SGMT Stock Option (Right to Buy) Award $0 +32,250 $0.000000 32,250 09 Jun 2025 Series A Common Stock 32,250 $5.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 6, 2025, subject to the Reporting Person's continued service on each such vesting date.
F2 The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date.